Table 2 Baseline characteristics according to PNI.
|  | low PNI ≤ 42.3 (n = 116) | high PNI > 42.3 (n = 692) | p-value |
|---|---|---|---|
Male, n (%) | 68 (58.6) | 445 (64.3) | 0.25 |
NIHSS (IQR) | 10 (6–16) | 7 (5–12) | < 0.001 |
BMI, kg/m2 (SD) | 23.4 (21.4–24.8) | 23.9 (21.8–25.7) | 0.04 |
SVO | 6 (5.2) | 115 (16.6) | Â |
LAA | 41 (35.3) | 200 (28.9) | Â |
CE | 38 (32.8) | 205 (29.6) | Â |
UD | 28 (24.1) | 152 (22.0) | Â |
OD | 3 (2.8) | 20 (2.9) | Â |
Interval from arrival to IVT, min (IQR) | 42 (35–56) | 39 (29–54) | 0.09 |
Previous stroke, n (%) | 23 (19.8) | 116 (16.8) | 0.43 |
HTN, n (%) | 68 (58.6) | 412 (59.5) | 0.92 |
CAD, n (%) | 14 (12.1) | 61 (8.8) | 0.30 |
Current smoking, n (%) | 22 (19.0) | 151 (21.8) | 0.54 |
Atrial fibrillation, n (%) | 44 (37.9) | 200 (28.9) | 0.06 |
Previous use of antithrombotics, n (%) | 25 (21.6) | 195 (28.2) | 0.15 |
tPA dose, n (%) | Â | Â | 0.06 |
0.6Â mg/kg | 7 (6.0) | 87 (12.6) | Â |
0.9Â mg/kg | 109 (94.0) | 605 (87.4) | Â |
Total cholesterol, mg/dL (SD) | 151.0 (44.9) | 173.1 (42.3) | 0.21 |
Albumin, mg/dL (SD) | 3.0 (0.7) | 4.2 (0.4) | < 0.001 |
Hemoglobin, g/dL (SD) | 13.5 (2.0) | 13.8 (2.0) | 0.16 |
Creatinine, mg/dL (SD) | 1.16 (0.88) | 0.97 (0.46) | 0.002 |
Platelet, x1000/µL (SD) | 222.3 (73.1) | 229.1 (70.1) | 0.32 |
LDL, mg/dL (SD) | 103.5 (38.4) | 106.2 (33.7) | 0.03 |
HbA1c, % (SD) | 6.0 (2.0) | 6.1 (1.1) | 0.27 |
Prothrombin time, INR (SD) | 1.04 (0.16) | 1.02 (0.12) | 0.35 |
CRP, mg/dL (SD) | 11.3 (27.8) | 7.0 (14.4) | 0.001 |
Initial random glucose, mg/dL (SD) | 151.5 (80.9) | 142.7 (52.6) | 0.004 |
SBP, mmHg (SD) | 153.3 (24.7) | 152.9 (27.7) | 0.16 |